Misplaced Pages

Detumomab

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is the current revision of this page, as edited by Entranced98 (talk | contribs) at 00:54, 14 May 2023 (Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound"). The present address (URL) is a permanent link to this version.

Revision as of 00:54, 14 May 2023 by Entranced98 (talk | contribs) (Adding local short description: "Monoclonal antibody", overriding Wikidata description "chemical compound")(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Monoclonal antibody Pharmaceutical compound
Detumomab
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetB-lymphoma cell
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (what is this?)  (verify)

Detumomab is a mouse monoclonal antibody targeting human B-cell lymphoma.

References

  1. "International Nonproprietary Names (INN) for Pharmaceutical Substances" (PDF). WHO Drug Information. 7 (4). 1993. Archived from the original (PDF) on 14 June 2007.
  2. Singh S, Kumar NK, Dwiwedi P, Charan J, Kaur R, Sidhu P, Chugh VK (2018). "Monoclonal Antibodies: A Review". Current Clinical Pharmacology. 13 (2): 85–99. doi:10.2174/1574884712666170809124728. PMID 28799485. S2CID 27211386.
Monoclonal antibodies for tumors
Tumor
Human
Mouse
Chimeric
Humanized
Rat/mouse hybrid
Chimeric + humanized


Stub icon

This monoclonal antibody–related article is a stub. You can help Misplaced Pages by expanding it.

Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Misplaced Pages by expanding it.

Categories: